Arch Med Res:葡萄糖转运蛋白1促癌细胞转移机制

2012-07-27 Beyond 生物谷

葡萄糖转运蛋白是一类专门运送葡萄糖的蛋白称为葡萄糖转运蛋白。它一共分4种:葡萄糖转运蛋白1~4(Glut1~4)。Glut4是一种类胰岛素敏感型葡萄糖运输载体,它与2型糖尿病密切相关,细胞中Glut4表达的减少以及其转位的障碍都是引发糖尿病的重要因素。 早期研究发现葡萄糖转运蛋白-1(Glut-1)与恶性肿瘤的生物学行为密切相关。然而,没有任何证据阐明Glut -1的过度表达对癌细胞侵袭转移机制

葡萄糖转运蛋白是一类专门运送葡萄糖的蛋白称为葡萄糖转运蛋白。它一共分4种:葡萄糖转运蛋白1~4(Glut1~4)。Glut4是一种类胰岛素敏感型葡萄糖运输载体,它与2型糖尿病密切相关,细胞中Glut4表达的减少以及其转位的障碍都是引发糖尿病的重要因素。

早期研究发现葡萄糖转运蛋白-1(Glut-1)与恶性肿瘤的生物学行为密切相关。然而,没有任何证据阐明Glut -1的过度表达对癌细胞侵袭转移机制。研究人员推测,Glut -1调节膜型金属蛋白酶-1(MT1-MMP)和基质金属蛋白酶-2(MMP-2)的表达促进癌细胞侵袭运动。

采用RT-PCR分析Glut -1、MMP-2、β-肌动蛋白、MT1-MMP的表达。Western印迹法检测Glut -1蛋白、MMP-2、MT1-MMP的表达。结果发现在Glut -1和MMP-2 mRNA和蛋白水平,两者共同表达于喉癌Hep-2喉癌细胞株中。

而在Hep-2喉癌细胞株转染Glut -1反义寡核苷酸(AS-ODN)后,MMP-2 mRNA和蛋白表达以及Glut -1 mRNA和蛋白表达出现下降。研究数据证实Glut -1和MMP-2的共表达在Hep-2喉癌细胞中,Glut -1可调节MMP-2和MT1-MMP的表达。

编译自:Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell by Antisense Glucose Transporter-1

doi:10.1016/j.arcmed.2012.07.003
PMC:
PMID:

Effect on the Expression of MMP-2, MT-MMP in Laryngeal Carcinoma Hep-2 Cell by Antisense Glucose Transporter-1

Ying-Ying Xua, Yang-Yang Baoa, Shui-Hong Zhoua, Jun Fanb

Background and Aims

Glucose transporter protein-1 (Glut-1) is correlated with biological behaviors of malignant tumors. However, there was no evidence that overexpression of Glut-1 mechanistically lead to invasion or metastasis of cancer cells. We hypothesized that Glut-1 regulates the expression of membrane type 1-MMP (MT1-MMP) and matrix metalloproteinase-2 (MMP-2).

Methods

Analysis of the expression of Glut-1, MMP-2, β-actin, and MT1-MMP was performed using RT-PCR. Expression of Glut-1 protein, MMP-2, and MT1-MMP was detected by Western blotting.

Results

At mRNA and protein levels, Glut-1 and MMP-2 were co-expressed in the Hep-2 laryngeal carcinoma cell line. After transfection, Glut-1 antisense oligodeoxynucleotide (AS-ODN) decreased the expression of MMP-2 mRNA and protein as well as Glut-1 mRNA and protein. Glut-1 AS-ODN also decreased the expression of MT1-MMP mRNA.

Conclusions

Co-expression of Glut-1 and MMP-2 in Hep-2 laryngeal carcinoma cells and Glut-1 may regulate MMP-2 and MT1-MMP expression.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2012-11-06 yzh409
  2. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2013-06-07 changhe722
  3. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2012-07-29 yxch36
  4. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
    2012-07-29 zz72
  5. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1696242, encodeId=a9f71696242f3, content=<a href='/topic/show?id=0107934e0a5' target=_blank style='color:#2F92EE;'>#转运#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93470, encryptionId=0107934e0a5, topicName=转运)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47c429881595, createdName=yzh409, createdTime=Tue Nov 06 21:57:00 CST 2012, time=2012-11-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677555, encodeId=0fe216e755531, content=<a href='/topic/show?id=fa5c2e100cd' target=_blank style='color:#2F92EE;'>#促癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27100, encryptionId=fa5c2e100cd, topicName=促癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ab727554053, createdName=changhe722, createdTime=Fri Jun 07 14:57:00 CST 2013, time=2013-06-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1251906, encodeId=0b73125190647, content=<a href='/topic/show?id=3efee1519b2' target=_blank style='color:#2F92EE;'>#癌细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71519, encryptionId=3efee1519b2, topicName=癌细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4cea26, createdName=yxch36, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1455887, encodeId=6f8e145588e3e, content=<a href='/topic/show?id=2920e8036d8' target=_blank style='color:#2F92EE;'>#细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78036, encryptionId=2920e8036d8, topicName=细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c3415750271, createdName=zz72, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1595892, encodeId=0a50159589287, content=<a href='/topic/show?id=bdcfe153376' target=_blank style='color:#2F92EE;'>#癌细胞转移#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71533, encryptionId=bdcfe153376, topicName=癌细胞转移)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=365518309389, createdName=yinhl1984, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605797, encodeId=05b11605e9791, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sun Jul 29 01:57:00 CST 2012, time=2012-07-29, status=1, ipAttribution=)]